Most Liquid Medical Equipment Companies

Cash And Equivalents
Cash And EquivalentsEfficiencyMarket RiskExp Return
1DRTSW Alpha Tau Medical
13.36 M
 0.09 
 17.72 
 1.67 
2KMTS Kestra Medical Technologies,
10.63 M
 0.18 
 5.66 
 1.03 
3ICUCW LMF Acquisition Opportunities
150.48 K
 0.12 
 9.77 
 1.17 
4DXCM DexCom Inc
2.37 B
(0.04)
 2.42 
(0.09)
5NVCR Novocure
948.52 M
(0.26)
 2.90 
(0.76)
6EW Edwards Lifesciences Corp
769 M
(0.06)
 1.65 
(0.09)
7NVST Envista Holdings Corp
523.1 M
(0.06)
 2.42 
(0.14)
8NVRO Nevro Corp
310.82 M
 0.15 
 4.59 
 0.70 
9EMBC Embecta Corp
292.3 M
(0.25)
 3.02 
(0.75)
10OM Outset Medical
227.52 M
(0.08)
 7.95 
(0.64)
11WRBY Warby Parker
211.6 M
(0.08)
 3.58 
(0.30)
12NYXH Nyxoah
123.32 M
 0.20 
 3.20 
 0.64 
13DRTS Alpha Tau Medical
112.04 M
(0.04)
 4.13 
(0.15)
14VTAK Catheter Precision
3.05 M
 0.00 
 5.44 
 0.02 
15NPCE Neuropace
92.41 M
 0.04 
 3.93 
 0.17 
16NNOX Nano X Imaging
86.63 M
(0.04)
 5.65 
(0.22)
17MDXG MiMedx Group
72.5 M
(0.13)
 1.77 
(0.23)
18EDAP EDAP TMS SA
68.33 M
 0.03 
 3.67 
 0.10 
19DRIO DarioHealth Corp
67.95 M
 0.06 
 13.00 
 0.73 
20ESTA Establishment Labs Holdings
65.35 M
 0.00 
 5.88 
(0.01)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes. Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).